APA
Spurdle A. B., Whiley P. J., Thompson B., Feng B., Healey S., Brown M. A., Pettigrew C., Van Asperen C. J., Ausems M. G. E. M., Kattentidt-Mouravieva A. A., van den Ouweland A. M. W., Lindblom A., Pigg M. H., Schmutzler R. K., Engel C., Meindl A., Caputo S., Sinilnikova O. M., Lidereau R., Couch F. J., Guidugli L., Hansen T. v. O., Thomassen M., Eccles D. M., Tucker K., Benitez J., Domchek S. M., Toland A. E., Van Rensburg E. J., Wappenschmidt B., Borg Å., Vreeswijk M. P. G. & Goldgar D. E. (20121228). BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk. : Journal of medical genetics.
Chicago
Spurdle Amanda B, Whiley Phillip J, Thompson Bryony, Feng Bingjian, Healey Sue, Brown Melissa A, Pettigrew Christopher, Van Asperen Christi J, Ausems Margreet G E M, Kattentidt-Mouravieva Anna A, van den Ouweland Ans M W, Lindblom Annika, Pigg Maritta H, Schmutzler Rita K, Engel Christoph, Meindl Alfons, Caputo Sandrine, Sinilnikova Olga M, Lidereau Rosette, Couch Fergus J, Guidugli Lucia, Hansen Thomas van Overeem, Thomassen Mads, Eccles Diana M, Tucker Kathy, Benitez Javier, Domchek Susan M, Toland Amanda E, Van Rensburg Elizabeth J, Wappenschmidt Barbara, Borg Åke, Vreeswijk Maaike P G and Goldgar David E. 20121228. BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk. : Journal of medical genetics.
Harvard
Spurdle A. B., Whiley P. J., Thompson B., Feng B., Healey S., Brown M. A., Pettigrew C., Van Asperen C. J., Ausems M. G. E. M., Kattentidt-Mouravieva A. A., van den Ouweland A. M. W., Lindblom A., Pigg M. H., Schmutzler R. K., Engel C., Meindl A., Caputo S., Sinilnikova O. M., Lidereau R., Couch F. J., Guidugli L., Hansen T. v. O., Thomassen M., Eccles D. M., Tucker K., Benitez J., Domchek S. M., Toland A. E., Van Rensburg E. J., Wappenschmidt B., Borg Å., Vreeswijk M. P. G. and Goldgar D. E. (20121228). BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk. : Journal of medical genetics.
MLA
Spurdle Amanda B, Whiley Phillip J, Thompson Bryony, Feng Bingjian, Healey Sue, Brown Melissa A, Pettigrew Christopher, Van Asperen Christi J, Ausems Margreet G E M, Kattentidt-Mouravieva Anna A, van den Ouweland Ans M W, Lindblom Annika, Pigg Maritta H, Schmutzler Rita K, Engel Christoph, Meindl Alfons, Caputo Sandrine, Sinilnikova Olga M, Lidereau Rosette, Couch Fergus J, Guidugli Lucia, Hansen Thomas van Overeem, Thomassen Mads, Eccles Diana M, Tucker Kathy, Benitez Javier, Domchek Susan M, Toland Amanda E, Van Rensburg Elizabeth J, Wappenschmidt Barbara, Borg Åke, Vreeswijk Maaike P G and Goldgar David E. BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk. : Journal of medical genetics. 20121228.